At this networking meeting, patent experts from Høiberg A/S will talk about why it is still possible to patent personalized medicine and diagnostic methods following the recent decision (Mayo vs. Prometheus) from the US Supreme Court?
You will be guide through the aftermath of the Prometheus decision. Additionally the meeting will focus on strategies to deal with the various exceptions on patenting of diagnostic methods in Europe, India, Japan, China and Korea.
22 May 2012
|08.00-08.30||Registration, breakfast and networking|
|08.40-09.30||Patenting personalized medicine post prometheus|
By Jens Viktor Nørgaard, EPA, PhD, MSc, Partner & Head of Biotech at Høiberg and Pernille Winding Gojkovic, CDPA, PhD, MSc, Partner at Høiberg
Good Morning Meetings are open for members and non-members of Medicon Valley Alliance.
MVA members and tenants of Scion DTU: Free of charge (late cancellation/no-show fee DKK 250)
Non members nor tenants of Scion DTU: DKK 2.000
Become a member of MVA here
In collaboration with
>>Back to Good Morning Meetings
Registration for this event has closed.